Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q2 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c